-
Biotech Stocks Busy In Takeovers: Celgene, Onyx Pharmaceuticals, Pfizer, Amgen, AbbVie, Johnson & Johnson, VIVUS, Intuitive Surgical, OXiGENE, Mast Therapeutics
In industry where takeovers are ordinary and small-cap biotechs burn from side to side cash rapidly, optimizing operating cash flow can be necessary to a firm’s financial health. As Celgene Corporation (NASDAQ:CELG) is a magnificent instance of a firm following label extension. Celgene has six accepted drugs on the market for treatment of cancer. Of…
-
Drug Maker In Pressure: Merck & Co., Inc. (NYSE:MRK) Face Lawsuit of $100 million
A sales person for Merck & Co., Inc. (NYSE:MRK) filed court case of overi$100M sex discrimination against the drugmaker, asserting that it mainly distinguishes alongside pregnant employees and women among children. In a claim filed in U.S. District Court in New Jersey, the claimant, Kelli Smith asserts she was downgraded for taking maternity leave in…